Cargando…
Sodium ion channel mutations in glioblastoma patients correlate with shorter survival
BACKGROUND: Glioblastoma Multiforme (GBM) is the most common and invasive astrocytic tumor associated with dismal prognosis. Treatment for GBM patients has advanced, but the median survival remains a meager 15 months. In a recent study, 20,000 genes from 21 GBM patients were sequenced that identifie...
Autores principales: | Joshi, Avadhut D, Parsons, D Williams, Velculescu, Victor E, Riggins, Gregory J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050859/ https://www.ncbi.nlm.nih.gov/pubmed/21314958 http://dx.doi.org/10.1186/1476-4598-10-17 |
Ejemplares similares
-
Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy
por: Joshi, Avadhut D., et al.
Publicado: (2012) -
Phospho-AXL is widely expressed in glioblastoma and associated with significant shorter overall survival
por: Onken, Julia, et al.
Publicado: (2017) -
Ion Channels in Glioblastoma
por: Molenaar, Remco J.
Publicado: (2011) -
ATM/RB1 mutations predict shorter overall survival in urothelial cancer
por: Yin, Ming, et al.
Publicado: (2018) -
IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma
por: Lugowska, Iwona, et al.
Publicado: (2018)